Patents by Inventor Michael James Earl

Michael James Earl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimised subcutaneous therapeutic agents
    Patent number: 11351112
    Abstract: Methods and dosage formulations are provided for subcutaneous administration in which therapeutic agents are modified to increase the hydrophilicity and molecular dimensions in relation to the native state of the therapeutic agent, in which the Cmax:Caverage ratio is lower than the Cmax:Caverage ratio of the agent when delivered intravenously.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: June 7, 2022
    Assignee: Cantab Biopharmaceuticals Patents Limited
    Inventors: William Henry, Richard Wolf-Garraway, John Charles Mayo, Michael James Earl
  • OPTIMISED SUBCUTANEOUS THERAPEUTIC AGENTS
    Publication number: 20180036229
    Abstract: Methods and dosage formulations are provided for subcutaneous administration in which therapeutic agents are modified to increase the hydrophilicity and molecular dimensions in relation to the native state of the therapeutic agent, in which the Cmax:Caverage ratio is lower than the Cmax:Caverage ratio of the agent when delivered intravenously.
    Type: Application
    Filed: August 30, 2017
    Publication date: February 8, 2018
    Applicant: Cantab Biopharmaceuticals Patents Limited
    Inventors: William HENRY, Richard WOLF-GARRAWAY, John Charles MAYO, Michael James EARL
  • OPTIMISED SUBCUTANEOUS THERAPEUTIC AGENTS
    Publication number: 20150086524
    Abstract: Methods and dosage formulations are provided for subcutaneous administration in which therapeutic agents are modified to increase the hydrophilicity and molecular dimensions in relation to the native state of the therapeutic agent, in which the Cmax:Caverage ratio is lower than the Cmax:Caverage ratio of the agent when delivered intravenously.
    Type: Application
    Filed: April 16, 2013
    Publication date: March 26, 2015
    Applicant: CANTAB BIOPHARMACEUTICALS PATENTS LIMITED
    Inventors: William Henry, Richard Wolf-Garraway, John Charles Mayo, Michael James Earl